Michael P. Cooke, Chief Scientific Officer at Magenta Therapeutics, Inc. (MGTA), sold 7,500 shares at $14.39 ($108K) on 2019-07-01, disclosed to the SEC on 2019-07-02.
Open-market sale of $108k MGTA by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.39 | 5,000 | $72K | 66.6% |
| 2 | $14.42 | 2,500 | $36K | 33.4% |
| Total | $14.40 avg | 7,500 | $108K | 100% |
| Filing → |
| MGTA | SELL | 2019-11-01 | $53K | — | Filing → |
| MGTA | SELL | 2019-10-03 | $50K | — | Filing → |
| MGTA | SELL | 2019-09-19 | $20K | — | Filing → |